BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

540 related articles for article (PubMed ID: 9929144)

  • 1. Enhancement of cisplatin sensitivity of quiescent cells in solid tumors by combined treatment with tirapazamine and low-temperature hyperthermia.
    Masunaga S; Ono K; Hori H; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1998; 16(6):441-8. PubMed ID: 9929144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation in chemosensitivity of intratumor quiescent cells by combined treatment with nicotinamide and mild hyperthermia.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Suzuki M; Kinashi Y; Takagaki M
    Jpn J Cancer Res; 1997 Aug; 88(8):770-7. PubMed ID: 9330609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The usefulness of continuous administration of hypoxic cytotoxin combined with mild temperature hyperthermia, with reference to effects on quiescent tumour cell populations.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Suzuki M; Nagata K; Kinashi Y; Ono K
    Int J Hyperthermia; 2005 Jun; 21(4):305-18. PubMed ID: 16019857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potentially lethal damage repair by total and quiescent tumor cells following various DNA-damaging treatments.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Radiat Med; 1999; 17(4):259-64. PubMed ID: 10510897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined effects of tirapazamine and mild hyperthermia on anti-angiogenic agent (TNP-470) treated tumors-reference to the effect on intratumor quiescent cells.
    Masunaga S; Ono K; Nishimura Y; Kanamori S; Saga T; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y; Hori H
    Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):799-807. PubMed ID: 10837967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
    Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
    Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination and drug modification assessed by micronucleus frequency assay of potentially lethal damage repair in quiescent cell populations within murine solid tumors.
    Masunaga S; Ono K; Akaboshi M; Takagaki M; Kinashi Y; Suzuki M; Abe M
    Radiat Med; 1997; 15(1):37-43. PubMed ID: 9134583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of the antivascular agent ZD6126 with hypoxic cytotoxin treatment, with reference to the effect on quiescent tumor cells and the dependency on p53 status of tumor cells.
    Masunaga S; Nagasawa H; Uto Y; Hori H; Ohnishi K; Takahashi A; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Oncol Rep; 2005 Aug; 14(2):393-400. PubMed ID: 16012721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of the vascular targeting agent ZD6126 with boron neutron capture therapy.
    Masunaga S; Sakurai Y; Suzuki M; Nagata K; Maruhashi A; Kinash Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):920-7. PubMed ID: 15465210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of combined treatment with mild temperature hyperthermia and/or tirapazamine in the treatment of solid tumors: its independence of p53 status.
    Masunaga S; Ono K; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Nagasawa H; Uto Y; Hori H
    Cancer Sci; 2003 Jan; 94(1):125-33. PubMed ID: 12708486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of tirapazamine-induced cytotoxicity in combination with mild hyperthermia and/or nicotinamide: reference to effect on quiescent tumour cells.
    Masunaga S; Ono K; Hori H; Kinashi Y; Suzuki M; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Int J Hyperthermia; 1999; 15(1):7-16. PubMed ID: 10193753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of tirapazamine as a combined agent in chemoradiation and thermo-chemoradiation therapy at mild temperatures: reference to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Suzuki M; Kinashi Y; Takagaki M; Hori H; Kasai S; Nagasawa H; Uto Y
    Jpn J Cancer Res; 2000 May; 91(5):566-72. PubMed ID: 10835503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of mild temperature hyperthermia and p53 status on the size of hypoxic fractions in solid tumors, with reference to the effect in intratumor quiescent cell populations.
    Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Nagata K; Suzuki M; Kinashi Y; Ono K
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):570-7. PubMed ID: 15380594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Change in oxygenation status in intratumour total and quiescent cells following gamma-ray irradiation, tirapazamine administration, cisplatin injection and bleomycin treatment.
    Masunaga S; Ono K; Hori H; Suzuki M; Kinashi Y; Takagaki M; Kasai S; Nagasawa H; Uto Y
    Br J Radiol; 2000 Sep; 73(873):978-86. PubMed ID: 11064652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Applicability of the 2-nitroimidazole-sodium borocaptate-10B conjugate, TX-2060, as a 10B-carrier in boron neutron capture therapy.
    Masunaga S; Nagasawa H; Hiraoka M; Sakurai Y; Uto Y; Hori H; Nagata K; Suzuki M; Maruhashi A; Kinashi Y; Ono K
    Anticancer Res; 2004; 24(5A):2975-83. PubMed ID: 15517904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the potential of p-boronophenylalaninol as a boron carrier in boron neutron capture therapy, referring to the effect on intratumor quiescent cells.
    Masunaga SI; Ono K; Kirihata M; Takagaki M; Sakurai Y; Kinashi Y; Kobayashi T; Nagasawa H; Uto Y; Hori H
    Jpn J Cancer Res; 2001 Sep; 92(9):996-1007. PubMed ID: 11572769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An attempt to enhance chemosensitivity of quiescent cell populations in solid tumors by combined treatment with nicotinamide and carbogen.
    Masunaga S; Ono K; Akaboshi M; Kawai K; Akuta K; Takagaki M; Suzuki M; Kinashi Y; Abe M
    J Cancer Res Clin Oncol; 1996; 122(9):533-40. PubMed ID: 8781567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of apoptosis and micronucleation induced by reactor neutron beams with two different cadmium ratios in total and quiescent cell populations within solid tumors.
    Masunaga S; Ono K; Sakurai Y; Takagaki M; Kobayashi T; Kinashi Y; Suzuki M
    Int J Radiat Oncol Biol Phys; 2001 Nov; 51(3):828-39. PubMed ID: 11697329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of p53 status and wortmannin treatment on potentially lethal damage repair, with emphasis on the response of intratumor quiescent cells.
    Masunaga S; Takahashi A; Ohnishi K; Ohnishi T; Suzuki M; Nagata K; Kinashi Y; Ono K
    Radiat Med; 2003; 21(3):120-7. PubMed ID: 12868860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the potential of hexamethylenetetramine, compared with tirapazamine, as a combined agent with {gamma}-irradiation and cisplatin treatment in vivo.
    Masunaga S; Tano K; Watanabe M; Kashino G; Suzuki M; Kinashi Y; Ono K; Nakamura J
    Br J Radiol; 2009 May; 82(977):392-400. PubMed ID: 19153181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.